Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors

NCT00002594 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Intensive Melphalan and Cyclophosphamide With Autologous Bone Marrow Rescue for Recurrent Medulloblastoma and Germ Cell Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
September 30, 1994
Completion date
March 31, 2007
Enrollment
31 (actual)
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, central nervous system tumor